comparemela.com

Latest Breaking News On - Amedisys company profile - Page 6 : comparemela.com

Amedisys (NASDAQ:AMED) Announces Quarterly Earnings Results, Misses Estimates By $0 10 EPS

Amedisys (NASDAQ:AMED – Get Free Report) released its quarterly earnings data on Tuesday. The health services provider reported $0.98 earnings per share for the quarter, missing the consensus estimate of $1.08 by ($0.10), Briefing.com reports. Amedisys had a net margin of 0.10% and a return on equity of 14.00%. The firm had revenue of $556.24 […]

Amedisys (NASDAQ:AMED) Now Covered by Analysts at StockNews com

StockNews.com initiated coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research note published on Sunday morning. The firm issued a buy rating on the health services provider’s stock. Other research analysts have also issued research reports about the stock. Jefferies Financial Group lowered shares of Amedisys from a buy rating to a […]

StockNews com Initiates Coverage on Amedisys (NASDAQ:AMED)

Equities researchers at StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Get Free Report) in a report released on Wednesday. The firm set a “buy” rating on the health services provider’s stock. AMED has been the subject of a number of other research reports. Barclays boosted their price target on Amedisys from $88.00 to […]

Amedisys (NASDAQ:AMED) Earns Buy Rating from Analysts at StockNews com

StockNews.com assumed coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report sent to investors on Monday. The brokerage issued a buy rating on the health services provider’s stock. A number of other research analysts have also commented on the company. Truist Financial upped their price target on Amedisys from $97.00 to […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.